Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease

American Journal of Kidney Diseases

Volumn 33, Issue 2, 1999, Pages 225-234

  Johnson, R J ^a   Kivlighn, S D ^a   Kim, Y G ^a   Suga, S ^a   Fogo, A B ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Gouty nephropathy; Hypertension; Tubulointerstitial disease; Uric acid

Indexed keywords

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; INTERSTITIAL NEPHRITIS; MORTALITY; PATHOGENESIS; REVIEW; RISK FACTOR; TREATMENT PLANNING; URIC ACID BLOOD LEVEL;

EID: 0033005975     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70295-7     Document Type: Article

References (82)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 157 1997 2413 2446
2. HJ Ward Uric acid as an independent risk factor in the treatment of hypertension Lancet 352 1998 670 671
3. F Jossa E Farinaro S Panico V Krogh E Celentano R Galasso M Mancini M Trevisan Serum uric acid and hypertension: The Olivetti heart study J Hum Hypertens 8 1994 677 681
4. JV Selby GD Friedman CP Quesenberry Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol and other serum chemistries Am J Epidemiol 131 1990 1017 1027
5. RD Abbott FN Brand WB Kannel WP Castelli Gout and coronary heart disease: The Framingham study J Clin Epidemiol 41 1988 237 242
6. DS Freedman DF Williamson EW Gunter T Byers Relation of serum uric acid to mortality and ischemic heart disease Am J Epidemiol 141 1995 637 644
7. TH Steele S Oppenheimer Factors affecting urate excretion following diuretic administration in man Am J Med 47 1969 564 574
8. PJ Cannon WB Stason FE Demartini SC Sommers JH Laragh Hyperuricemia in primary and renal hypertension N Engl J Med 275 1966 457 464
9. A Breckenridge Hypertension and hyperuricaemia Lancet 1 1966 15 18
10. A Tykarski Evaluation of renal handling of uric acid in essential hypertension: Hyperuricemia related to decreased urate secretion Nephron 59 1991 364 368
11. CJ Bulpitt Serum uric acid in hypertensive patients Br Heart J 37 1975 1210 1215
12. K Hiyamuta H Toshima Y Koga H Nakayama A Yamaga A Shiraishi H Maruyama Y Hidaka T Ueno O Yoahiga J Shibata H Ikeda H Tashiro M Yoh K Harada Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis Jpn Circ J 59 1990 442 447
13. C Bengtsson L Lapidus C Stendahl J Waldenstrom Hyperuricaemia and risk of cardiovascular disease and overall death: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden Acta Med Scand 224 1988 549 555
14. VW Persky AR Dyer E Idris-Soven J Stamler RB Shekelle JA Schoenberger DM Berkson HA Lindberg Uric acid: A risk factor for coronary heart disease? Circulation 59 1979 969 977
15. HG Langford MD Blaufox NO Borhani JD Curb A Molteni KA Schneider S Pressel Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-Up Program Arch Intern Med 147 1987 645 649
16. E Casiglia P Spolaore G Ginocchio G Colangeli G Di-Menza M Marchioro A Mazza GB Ambrosio Predictors of mortality in very old subjects aged 80 years or over Eur J Epidemiol 9 1993 577 586
17. S Lehto L Niskanen T Rönnemaa M Laakso Serum uric acid is a strong predictor of stroke in patients with non–insulin-dependent diabetes mellitus Stroke 29 1998 635 639
18. JS Cameron F Moro HA Simmonds Uric acid and the kidney All Davison JS Cameron J-P Grünfeld DS Kerr E Ritz CG Winearls The Oxford Textbook of Clinical Nephrology 1998 Oxford Medical Oxford, UK 1157 1173
19. F Roch-Ramel B Guisan J Diezi Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles J Pharm Exp Ther 280 1997 839 845
20. LB Sorensen Role of the intestinal tract in the elimination of uric acid Arthritis Rheum 8 1965 694 706
21. A Nicholls ML Snaith JT Scott Effect of oestrogen therapy on plasma and urinary levels BMJ 1 1973 449 451
22. RJ Glynn EW Campion JE Silbert Trends in serum uric acid levels Arthritis Rheum 26 1983 87 93
23. J Faller IH Fox Ethanol-induced hyperuricemia: Evidence for increased urate production by activation of adenine nucleotide turnover N Engl J Med 307 1982 1598 1602
24. F Saggiani S Pilati G Targher P Branzi M Muggeo E Bonora Serum uric acid and related factors in 500 hospitalized subjects Metabolism 45 1996 1557 1561
25. LE Ramsay Hyperuricaemia in hypertension: Role of alcohol BMJ 1 1979 653 654
26. CS Lieber DP Jones MS Losowsky CS Davidson Interrelation of uric acid and ethanol metabolism in man J Clin Invest 4 1962 1863 1870
27. MJ Maclachlan GP Rodnan Effects of food, fast and alcohol on serum uric acid and acute attacks of gout Am J Med 42 1967 38 57
28. MJ Rieder RJ Roman AS Greene Reversal of microvascular rarefaction and reduced renal mass hypertension Hypertension 30 1997 120 127
29. A Bohle G Muller M Wehrmann S Mackensen-Haen J-C Xio Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides Kidney Int 49 suppl 54 1996 S2 S9
30. JS Roy JM McCord Superoxide and ischemia: Conversion of xanthine dehydrogenase to xanthine oxidase RA Greenwald G Cohen Free Radicals and Their Scavenger System 1983 Elsevier New York, NY 145 153
31. A Many CA Hubel JM Roberts Hyperuricemia and xanthine oxidase in preeclampsia, revisited Am J Obstet Gynecol 174 1996 288 291
32. HP Friedl GO Till O Trentz PA Ward Role of oxygen radicals in tourniquet-related ischemia reperfusion injury of human patients Klin Wochenschr 69 1991 1109 1112
33. IK DeScheerder AM van de Kraay JM Lamers JF Koster JW de Jong PW Serruys Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: Potential mechanisms for free radical generation Am J Cardiol 68 1991 392 395
34. RJ Johnson GF Schreiner Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension Kidney Int 52 1997 1169 1179
35. RJ Johnson A Bidani T Andoh D Lombardi K Gordon K Griffin G Schreiner WM Bennett A role for the peritubular capillaries and tubulointerstitium in the development of salt-dependent hypertension J Am Soc Neph 8 1997 301A (abstr)
36. FH Messerli ED Frohlich GR Dreslinski DH Suarez GG Aristimuno Serum uric acid in essential hypertension: An indicator of renal vascular involvement Arch Intern Med 93 1980 817 821
37. TF Ferris P Gorden Effect of angiotensin and norepinephrine upon urate clearance in man Am J Med 44 1968 359 365
38. F Cappuccio R Iacone P Strazzullo Serum uric acid and proximal sodium excretion: An independent association in man (the Olivetti study) J Hypertens 9 1991 S280 S281
39. R Roubenoff Gout and hyperuricemia Epidem Rheum Dis 16 1990 539 551
40. CM Wise CA Agudelo Gouty arthritis and uric acid metabolism Curr Opin Rheum 8 1996 248 254
41. GM Reaven The kidney: An unwilling accomplice in syndrome X Am J Kidney Dis 30 1997 928 932
42. R Marcen N Gallego L Orofino C Gamez MR Estepa J Sabater JL Teruel J Ortuno Impairment of tubular secretion of urate in renal transplant patients on cyclosporine Nephron 70 1995 307 313
43. BL Kasiske JT Crosson Renal disease in patients with massive obesity Arch Intern Med 146 1993 160 164
44. A Fogo JA Breyer MC Smith WH Cleveland L Agodoa KA Kirk R Glassorck AASK Pilot Study Investigators Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial Kidney Int 51 1997 244 252
45. SE Thomas S Anderson KL Gordon TT Oyama SJ Shankland RJ Johnson Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia J Am Soc Neph 9 1958 231 242
46. V Batuman JK Maesaka B Haddad E Tepper E Landy RP Wedeen The role of lead in gout nephropathy N Engl J Med 304 1981 520 523
47. WM Bennett A DeMattos MM Meyer T Andoh JM Barry Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy Kidney Int 50 1996 1089 1100
48. AI Sánchez-Fructuoso A Torralbo M Arroyo M Luque LM Ruilope JL Santos A Cruceyra A Barrientos Occult lead intoxication as a cause of hypertension and renal failure Nephrol Dial Transplant 11 1996 1775 1780
49. JJ Curtis RG Luke P Jones AG Diethelm Hypertension in cyclosporine renal transplant recipients is sodium dependent Am J Med 85 1998 134 138
50. R Pichler N Franceshini B Young C Hugo T Andoh E Burdmann S Shankland CE Alpers WM Bennett WG Couser RJ Johnson Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin J Am Soc Nephrol 6 1995 1186 1196
51. RS Nanra P Bastian M Howard V Daniel Secondary gout in analgesic nephropathy Aust N Z J Med 8 1978 237
52. G Kuster E Ritz Analgesic abuse and hypertension Lancet 2 1989 1105
53. JS Cameron F Moro M McBride HA Simmonds Inherited disorder of purine metabolism and transport ALL Davison JS Cameron J-P Grünfeld DS Kerr E Ritz CG Winearls The Oxford Textbook of Clinical Nephrology, 1998 1997 Oxford Medical Oxford, UK 2469 2482
54. FA Mateos JC Puig Renal hemodynamics in familial nephropathy associated with hyperuricemia Adv Exp Med Biol 309 1991 301 304
55. FJ Mart'inez JM Sancho Rof Epidemiology of high blood pressure and obesity Drugs 46 1993 160 164
56. J Staessen The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly Trial Am J Med 90 1991 50S 54S
57. FN Brand DL McGee WB Kannel J Stokes III WP Castelli Hyperuricemia as a risk factor of coronary heart disease: The Framingham study Am J Epidemiol 121 1985 11 18
58. EF Traut AA Knight PB Szanto EW Passerelli Specific vascular changes in gout JAMA 156 1954 591 593
59. JJ Bunim C McEwan Tophus of mitral valve in gout Arch Pathol 29 1940 700 704
60. MH Ginsberg F Kozin M O'Malley DJ McCarty Release of platelet constituents by monosodium urate crystals J Clin Invest 60 1997 999 1007
61. JF Mustard EA Murphy MA Ogryzlo HA Smythe Blood coagulation and platelet economy in subjects with primary gout Can Med Assoc J 89 1963 1207 1211
62. H Newland Hyperuriciemia in coronary, cerebral and peripheral arterial disease: An explanation Med Hypotheses 1 1975 152 155
63. L Beck Requiem for gouty nephropathy Kidney Int 30 1986 280 287
64. JH Talbott KL Terplan The kidney in gout Medicine 39 1960 405 467
65. D-C Tarng H-Y Lin M-L Shyong J-S Wang W-C Yang T-P Huang Renal function in gout patients Am J Nephrol 15 1995 31 37
66. HC Gonick MD Rubini IO Gleason SC Sommers The renal lesion in gout Ann Intern Med 62 1965 667 674
67. H Oliva A Barat Histopathology of the kidney in percutaneous biopsy in gout T Yü L Berger The Kidney in Gout and Hyperuricemia 1982 Futura Mount Kisco, NY 175 194
68. T Yü L Berger DJ Dorph H Smith Renal function in gout: V. Factors influencing the renal hemodynamics Am J Med 67 1979 766 771
69. L Berger T Yü Renal function in gout: IV. An analysis of 524 gouty subjects including long-term follow-up studies Am J Med 59 1975 605 613
70. TP Gordon R Terkeltaub MH Ginsberg Gout: Crystal-induced inflammation JI Gallin IM Goldstein R Snyderman Inflammation: Basic Principles and Clinical Correlates 1988 Raven New York, NY 775 783
71. V Nickeleit MJ Mihatsch Uric acid nephropathy and end stage renal disease—Review of a non-disease Nephrol Dial Tranplant 12 1997 1832 1838
72. WJ Fessel Renal outcomes of gout and hyperuricemia Am J Med 67 1979 74 82
73. T Yü L Berger Impaired renal function in gout: Its association with hypertensive vascular disease and intrinsic renal disease Am J Med 72 1982 95 100
74. BI Freedman SS Iskandar RG Appel The link between hypertension and nephrosclerosis Am J Kidney Dis 25 1995 207 221
75. JW Linnane AF Burry BT Emmerson Urate deposits in the renal medulla: Prevalence and associations Nephron 29 1981 216 222
76. PJ Cannon PS Symchych FE Demartini The distribution of urate in human and primate kidney Proc Soc Exp Biol 129 1968 278 284
77. JB Rosenfeld Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects Adv Exp Med Biol 41B 1974 581 596
78. RK Patial VK Sehgal Non-oliguric acute renal failure in gout Indian J Med Sci 46 1992 201 204
79. F Moro HA Simmonds JS Cameron CS Ogg GD Williams MB McBride PM Davis Does allopurinal affect the progression of familial juvenile gouty nephropathy? Adv Exp Med Biol 309A 1991 199 202
80. JG Puig M Miranda FA Mateos ML Picazo TS Calvin AA Gil Hereditary nephropathy associated with hyperuricemia and gout Arch Intern Med 153 1993 357 365
81. M Burnier M Hagman J Nussberger J Biollaz C Armagnac R Brouard B Waeber HR Brunner Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects Hypertension 25 1995 602 609
82. M Burnier F Roch-Ramel HR Brunner Renal effects of angiotensin II receptor blockade in normotensive subjects Kidney Int 49 1996 1787 1790